CD19/CD3 epsilon Blinatumomab Mouse Monoclonal Antibody
Blinatumomabis a research-grade recombinant antibody targeting CD19. Produced in mammalian cells with native-like glycosylation. Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
CD19, Differentiation antigen CD19, T-cell surface antigen Leu-12, B-lymphocyte antigen CD19, B-lymphocyte surface antigen B4, T3E, T-cell surface antigen T3/Leu-4 epsilon chain, CD3e, CD3E, T-cell surface glycoprotein CD3 epsilon chain
UniProt
P15391, P07766
Reactivity
Human
Target
CD19, CD3 epsilon
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Purified by Nickel column.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Mouse
Preservative
30 mM Histidine, pH5.8, 10% sucrose, 0.02% Tween80
Isotype
(scFv-kappa-heavy) - (scFv-heavy-kappa)
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
